Parkinson's Disease Center and Movement Disorders Clinic

Click on the Expand plus sign sign to list the poster and platform presentations by year. Then click on the link to view that presentation.

2023

Collapse All | Expand All

 

    American Academy of Neurology (AAN)
    75th Annual Meeting in Boston, Mass. (April 22-28, 2023)
    • Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis and retrocollis.

      Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

    • Spinocerebellar ataxia 21 and phenotypic variability within a single family.

      Hull M, Parnes M, Jankovic J

    • Apathy and Parkinson's disease motor phenotypes: A preliminary study.

      Lenka A, Gazes Y, Vanegas-Arroyave N

    • Precision neurology for dementia.

      Shulman J, Vanegas-Arroyave N, Fong J, Elsea S, Lin C, Saade H, et al.

2022

Collapse All | Expand All

 

    Movement Disorder Society (MDS)
    26th International Congress of Parkinson's Disease and Movement Disorders in Madrid, Spain (Sept. 15-18, 2022)
    • Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis subtype of cervical dystonia.

      Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

    • Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with retrocollis subtype of cervical dystonia.

      Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

    • Spinocerebellar ataxia 21 and phenotypic variability within a family.

      Hull M, Parnes M, Jankovic J

    • Neuroanatomical underpinnings of apathy in Parkinson's disease.

      Le Heron C, Huey E, Vanegas-Arroyave N, Gazes Y, Lee S

    • How does head tremor in cervical dystonia change with head position?

      Vu J, Cisneros E, Zhao J, Jankovic J, Factor S, Goetz C, et al.

    International Neurotoxin Association (INA)
    Toxins 2022 6th International Conference in New Orleans, La. (July 27-30, 2022)
    • Characteristics and treatment response to onabotulinumtoxinA of patients from CD-PROBE with anterocollis and retrocollis.

      Dashtipour K, Jankovic J, Charles D, Mehta S, Schwartz M, Sadeghi M

    American Academy of Neurology (AAN)
    74th Annual Meeting in Seattle, Wash. (April 2-7, 2022)
    • Neutralizing antibody conversion with onabotulinumtoxinA from global studies across multiple indications in nearly 30,000 patient records: A meta-analysis.
      [Previously Presented]

      Jankovic J, Carruthers J, Naumann M, Boodhoo T, Gupta S, Attar M, et al.

    • A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.

      Jankovic J, Comella C, Hauser RA, Patel AT, Gross TM, Rubio RG, et al.

2021

Collapse All | Expand All

 

    Movement Disorder Society (MDS)
    Virtual International Congress of Parkinson's Disease and Movement Disorders. (Sept. 17-22, 2021)
    American Academy of Neurology (AAN)
    Virtual 2021 Annual Meeting (April 17-22, 2021)
    • A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.

      Jankovic J, Comella C, Hauser RA, Patel AT, Gross TM, Rubio RG, et al.

    International Neurotoxin Association (INA)
    Virtual Conference (Jan. 16-17, 2021)
    • Neutralizing antibody conversion with onabotulinumtoxinA from global studies across multiple indications in nearly 30,000 patient records: A meta-analysis.

      Jankovic J, Carruthers J, Naumann M, Boodhoo T, Gupta S, Attar M, et al.

    • A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia.

      Jankovic J, Comella C, Hauser RA, Patel AT, Gross TM, Rubio RG, et al.

    • Duration of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naive subjects: Results from a phase III study.

      Mitsikostas DD, Dekundy A, Althaus M, Scheschonka A, Pagan F, Jankovic J

<2020

Collapse All | Expand All